- Home
- ALRM vs RARE Comparison
ALRM vs RARE Comparison
Compare ALRM & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRM
- RARE
- Stock Information
- Founded
- ALRM 2000
- RARE 2010
- Country
- ALRM United States
- RARE United States
- Employees
- ALRM N/A
- RARE N/A
- Industry
- ALRM Computer Software: Prepackaged Software
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- ALRM Technology
- RARE Health Care
- Exchange
- ALRM Nasdaq
- RARE Nasdaq
- Market Cap
- ALRM 2.8B
- RARE 2.6B
- IPO Year
- ALRM 2015
- RARE 2014
- Fundamental
- Price
- ALRM $55.22
- RARE $28.71
- Analyst Decision
- ALRM Buy
- RARE Strong Buy
- Analyst Count
- ALRM 6
- RARE 14
- Target Price
- ALRM $64.33
- RARE $86.64
- AVG Volume (30 Days)
- ALRM 319.0K
- RARE 1.4M
- Earning Date
- ALRM 11-06-2025
- RARE 11-04-2025
- Dividend Yield
- ALRM N/A
- RARE N/A
- EPS Growth
- ALRM 17.96
- RARE N/A
- EPS
- ALRM 2.37
- RARE N/A
- Revenue
- ALRM $975,867,000.00
- RARE $610,159,000.00
- Revenue This Year
- ALRM $7.68
- RARE $19.72
- Revenue Next Year
- ALRM $4.35
- RARE $23.29
- P/E Ratio
- ALRM $23.26
- RARE N/A
- Revenue Growth
- ALRM 7.81
- RARE 26.77
- 52 Week Low
- ALRM $48.23
- RARE $25.81
- 52 Week High
- ALRM $70.06
- RARE $59.90
- Technical
- Relative Strength Index (RSI)
- ALRM 42.80
- RARE 39.94
- Support Level
- ALRM $55.00
- RARE $28.96
- Resistance Level
- ALRM $56.85
- RARE $31.80
- Average True Range (ATR)
- ALRM 1.12
- RARE 1.00
- MACD
- ALRM -0.28
- RARE -0.24
- Stochastic Oscillator
- ALRM 5.02
- RARE 2.27
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.